Sherry Aulin | CFO |
Ian Mortimer | President and CEO |
Chris Kenney | CMO |
Chris Von Seggern | CCO |
Brian Abrahams | RBC Capital Markets |
Tessa Romero | JPMorgan |
Paul Choi | Goldman Sachs |
Joseph Thome | TD Cowen |
Andrew Tsai | Jefferies |
Rudy Li | SVB Securities |
Laura Chico | Wedbush |
Rohit Bhasin | Needham & Company |
Ladies and gentlemen, thank you for standing by, and welcome to the Q4 2022 Xenon Pharmaceuticals, Inc. Earnings Conference Call.
I would now like to turn the call over to Sherry Aulin, CFO. Please go ahead.
Good afternoon.